http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101321055-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4439 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4439 |
| filingDate | 2009-11-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2013-10-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2013-10-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101321055-B1 |
| titleOfInvention | Novel crystalline forms of dexlansoprazole and pharmaceutical compositions comprising the same |
| abstract | Crystalline (+)-lansoprazole, which comprises a major peak in the X-ray diffraction spectrum having a relative intensity of 20% or more at a distance (d value) between diffraction planes of 17.4 Hz, is homogeneous, nonhygroscopic and stable. Pharmaceutical compositions comprising crystals are useful for the treatment or prevention of gastric acid-related diseases. |
| priorityDate | 2008-11-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 32.